Every 10-Q that Aemetis, Inc. (DE) (AMTX) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow AMTX and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full AMTX filings page.
Aemetis, Inc. reported Q2 2026 results with revenue of $62.7 million, up from $52.2 million a year earlier, and a narrowed net loss of $9.4 million versus $23.4 million. Gross profit turned positive at $13.5 million and operating income reached $5.8 million, driven by stronger California ethanol and renewable natural gas activity and recognition of Section 45Z production tax credits within revenue.
For the first half of 2026, revenue was $117.3 million and net loss was $31.1 million. Interest and related costs remained heavy at $31.2 million year‑to‑date, reflecting substantial borrowings. Total debt was $415.9 million, with $354.2 million classified as current, while total assets were $289.2 million and stockholders’ deficit was $322.1 million. Cash, cash equivalents, and restricted cash were $3.5 million, and operating activities used $12.4 million of cash in the first half.
Management discloses substantial doubt about the company’s ability to continue as a going concern over the next twelve months, citing high leverage, dependence on its senior lender, near‑term maturities, and required redemption or refinancing of $130.2 million of Series A preferred units. Plans to address liquidity include monetizing Section 45Z credits, optimizing plant operations, expanding dairy RNG projects, continuing equity issuance, and pursuing refinancings and project‑level financing.
Aemetis, Inc. reported first‑quarter 2026 revenue of $54.6 million, up from $42.9 million, driven by strong growth in India biodiesel and California renewable natural gas plus new Section 45Z production tax credits.
Gross profit improved to $2.8 million from a $5.1 million loss, but the company still posted a net loss of $21.7 million and used $10.6 million of cash in operating activities. Total debt reached $404.7 million, with $342.6 million classified as current and several facilities due on demand. Management discloses substantial doubt about the company’s ability to continue as a going concern absent refinancing, additional financing, and continued cooperation from its senior lender.
Aemetis, Inc. filed its Q3 2025 10‑Q, reporting revenue of $59.2 million for the quarter and a net loss of $23.7 million. For the nine months, revenue was $154.3 million with a net loss of $71.7 million.
Quarterly results reflected softer biodiesel sales in India and a near break‑even gross margin, while SG&A was $8.5 million. Interest and financing costs remained heavy, with quarterly interest expense of $11.9 million and total other debt‑related costs of $3.3 million.
As of September 30, 2025, cash and equivalents were $5.6 million ($8.6 million including restricted), total debt was $353.5 million, and the ABGL Series A preferred units liability was $131.0 million. The company recorded $16.4 million net cash provided by financing year‑to‑date and $(2.5) million net cash used in operations. Shares outstanding were 65.0 million as of September 30, 2025, and 65,568,542 as of October 31, 2025.
ABGL’s Series A preferred redemption deadline was extended to December 31, 2025; if not redeemed, a credit agreement effective January 1, 2026 would replace it at an interest rate equal to the greater of prime + 10.0% or 16.0%.